// App-Quantinova.ai

: The Estimated Impact of New Therapies on Factor VIII (FVIII) Use and Product Cost by 2023

Researchers

Presenter

  • J. Ducore

Principal Investigators

  • J. Stonebraker

Medical Centers

  • UC Davis Hemostasis and Thrombosis Center, Hemostasis and Thrombosis Center, Sacramento, United States

  • North Carolina State University, Graduate School of Business, Raleigh, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Hemophilia

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • FVIII

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved